Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1991 Dec;32(6):669–670.

Population pharmacokinetics: theory and practice.

L Aarons 1
PMCID: PMC1368544  PMID: 1768557

Full text

PDF
670

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abernethy D. R., Azarnoff D. L. Pharmacokinetic investigations in elderly patients. Clinical and ethical considerations. Clin Pharmacokinet. 1990 Aug;19(2):89–93. doi: 10.2165/00003088-199019020-00001. [DOI] [PubMed] [Google Scholar]
  2. Amisaki T., Tatsuhara T. An alternative two stage method via the EM-algorithm for the estimation of population pharmacokinetic parameters. J Pharmacobiodyn. 1988 May;11(5):335–348. doi: 10.1248/bpb1978.11.335. [DOI] [PubMed] [Google Scholar]
  3. Beal S. L., Sheiner L. B. Estimating population kinetics. Crit Rev Biomed Eng. 1982;8(3):195–222. [PubMed] [Google Scholar]
  4. Colburn W. A. Controversy. IV: Population pharmacokinetics, NONMEM and the pharmacokinetic screen; academic, industrial and regulatory perspectives. J Clin Pharmacol. 1989 Jan;29(1):1–6. doi: 10.1002/j.1552-4604.1989.tb03230.x. [DOI] [PubMed] [Google Scholar]
  5. Driscoll M. S., Ludden T. M., Casto D. T., Littlefield L. C. Evaluation of theophylline pharmacokinetics in a pediatric population using mixed effects models. J Pharmacokinet Biopharm. 1989 Apr;17(2):141–168. doi: 10.1007/BF01059025. [DOI] [PubMed] [Google Scholar]
  6. Gitterman S. R., Drusano G. L., Egorin M. J., Standiford H. C. Population pharmacokinetics of zidovudine. The Veterans Administration Cooperative Studies Group. Clin Pharmacol Ther. 1990 Aug;48(2):161–167. doi: 10.1038/clpt.1990.131. [DOI] [PubMed] [Google Scholar]
  7. Grasela T. H., Jr, Antal E. J., Townsend R. J., Smith R. B. An evaluation of population pharmacokinetics in therapeutic trials. Part I. Comparison of methodologies. Clin Pharmacol Ther. 1986 Jun;39(6):605–612. doi: 10.1038/clpt.1986.107. [DOI] [PubMed] [Google Scholar]
  8. Graves N. M., Ludden T. M., Holmes G. B., Fuerst R. H., Leppik I. E. Pharmacokinetics of felbamate, a novel antiepileptic drug: application of mixed-effect modeling to clinical trials. Pharmacotherapy. 1989;9(6):372–376. doi: 10.1002/j.1875-9114.1989.tb04151.x. [DOI] [PubMed] [Google Scholar]
  9. Kelman A. W., Thomson A. H., Whiting B., Bryson S. M., Steedman D. A., Mawer G. E., Samba-Donga L. A. Estimation of gentamicin clearance and volume of distribution in neonates and young children. Br J Clin Pharmacol. 1984 Nov;18(5):685–692. doi: 10.1111/j.1365-2125.1984.tb02530.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Launay M. C., Iliadis A., Richard B. Population pharmacokinetics of mitoxantrone performed by a NONMEM method. J Pharm Sci. 1989 Oct;78(10):877–880. doi: 10.1002/jps.2600781020. [DOI] [PubMed] [Google Scholar]
  11. Lindstrom M. L., Bates D. M. Nonlinear mixed effects models for repeated measures data. Biometrics. 1990 Sep;46(3):673–687. [PubMed] [Google Scholar]
  12. Moore E. S., Faix R. G., Banagale R. C., Grasela T. H. The population pharmacokinetics of theophylline in neonates and young infants. J Pharmacokinet Biopharm. 1989 Feb;17(1):47–66. doi: 10.1007/BF01059087. [DOI] [PubMed] [Google Scholar]
  13. Sheiner L. B., Beal S. L. Bayesian individualization of pharmacokinetics: simple implementation and comparison with non-Bayesian methods. J Pharm Sci. 1982 Dec;71(12):1344–1348. doi: 10.1002/jps.2600711209. [DOI] [PubMed] [Google Scholar]
  14. Sheiner L. B., Benet L. Z. Premarketing observational studies of population pharmacokinetics of new drugs. Clin Pharmacol Ther. 1985 Nov;38(5):481–487. doi: 10.1038/clpt.1985.212. [DOI] [PubMed] [Google Scholar]
  15. Steimer J. L., Mallet A., Golmard J. L., Boisvieux J. F. Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model. Drug Metab Rev. 1984;15(1-2):265–292. doi: 10.3109/03602538409015066. [DOI] [PubMed] [Google Scholar]
  16. Vozeh S., Steiner C. Estimates of the population pharmacokinetic parameters and performance of Bayesian feedback: a sensitivity analysis. J Pharmacokinet Biopharm. 1987 Oct;15(5):511–528. doi: 10.1007/BF01061760. [DOI] [PubMed] [Google Scholar]
  17. Whiting B., Kelman A. W., Grevel J. Population pharmacokinetics. Theory and clinical application. Clin Pharmacokinet. 1986 Sep-Oct;11(5):387–401. doi: 10.2165/00003088-198611050-00004. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES